Parco Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 20-12-2024
- Paid Up Capital ₹ 0.85 M
as on 20-12-2024
- Company Age 40 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.37 M
as on 20-12-2024
About Parco Pharmaceuticals
The Company is engaged in the Plastics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.85 M.
The company has closed loans amounting to ₹1.37 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vijaykumar Inamdar, Vandana Inamdar, and Shardul Inamdar serve as directors at the Company.
- CIN/LLPIN
U24239PN1984PTC033640
- Company No.
033640
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 1984
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Parco Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijaykumar Inamdar  | Director | 01-Aug-1984 | Current |
| Vandana Inamdar | Director | 16-Jul-2024 | Current |
| Shardul Inamdar | Director | 24-Jul-2024 | Current |
Financial Performance of Parco Pharmaceuticals.
Parco Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Parco Pharmaceuticals?
In 2017, Parco Pharmaceuticals had a promoter holding of 53.08% and a public holding of 46.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The United Western Bank Ltd Creation Date: 29 Oct 1994 | ₹0.42 M | Satisfied |
The United Western Bank Ltd Creation Date: 12 Oct 1994 | ₹0.65 M | Satisfied |
The Sangli Bank Ltd. Creation Date: 24 Apr 1991 | ₹0.15 M | Satisfied |
How Many Employees Work at Parco Pharmaceuticals?
Unlock and access historical data on people associated with Parco Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parco Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parco Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
